A Pilot of Metformin Postpartum
The overall goal of this proposal is to assess metformin initiation at the time of hospital discharge for women with a history of gestational diabetes mellitus (GDM) improves maternal health at 1 year post-partum. Our central hypothesis is that diabetes mellitus (DM) prevention with metformin can be initiated days after delivery, rather than months to years after delivery, and result in a pragmatic and efficacious means of preventing DM and improving weight loss over the first year post-partum. To test this hypothesis, we will perform a open-label randomized controlled trial of metformin compared to placebo routine care initiated at the time of hospital discharge in women with a history of GDM.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
200
Medication
Women & Infants Hospital
Providence, Rhode Island, United States
RECRUITINGPrediabetes or Diabetes
glycosylated hemoglobin (HgbA1c) at 1 year postpartum (\>/= 5.7% defined as prediabetes, \>/=6.5% defined as DM
Time frame: 1 year postpartum
Prediabetes or diabetes at 15 months postpartum
HgbA1c at 15 months postpartum
Time frame: 15 months after delivery and study initiation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.